Meridian signs distribution deal:
This article was originally published in Clinica
Meridian Diagnostics has signed a multi-year agreement with Physician Sales & Service, giving PSS exclusive sales to physicians' offices of Meridian's Filtracheck-UTI one-minute urinary tract infection test. In addition the distributor gets non-exclusive rights to Meridian's other rapid tests, including mycoplasma, infectious mononucleosis, and H pylori.
You may also be interested in...
Health policy changes that President-elect Joe Biden will likely make during his four-year term include Medicaid expansion and a greater reliance on medical science, among others, experts say.
Already cleared to monitor the viral load in HIV-positive individuals, the test has now been approved for initial diagnosis as well.
As with its first two approved RNAi therapies, Alnylam will negotiate value-based agreements with payers, but for Oxlumo, approved in pediatric patients, it will offer a patient need adjustment.